Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Jun 27, 2022; 14(6): 567-579
Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.567
Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.567
Table 2 Summary of long-term efficacy and safety
| Items | 6 mo | 12 mo | 24 mo |
| Cumulative survival rate (%) | 83.1 | 49.7 | 21.8 |
| Cumulative rate of shunt stenosis (%) | 13.3 | 28.9 | 38.6 |
| Cumulative recurrence rate of CPH (%) | 9.6 | 22.9 | 33.7 |
- Citation: Yan XH, Yue ZD, Zhao HW, Wang L, Fan ZH, Wu YF, Meng MM, Zhang K, Jiang L, Ding HG, Zhang YN, Yang YP, Liu FQ. Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension. World J Gastrointest Surg 2022; 14(6): 567-579
- URL: https://www.wjgnet.com/1948-9366/full/v14/i6/567.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i6.567